-+ 0.00%
-+ 0.00%
-+ 0.00%

Anavex Life Sciences files Form 3 for Interim CEO Terrie Kellmeyer

PUBT·05/14/2026 20:17:18
Listen to the news
Anavex Life Sciences files Form 3 for Interim CEO Terrie Kellmeyer
  • Anavex Life Sciences Form 3 showed interim CEO Terrie Kellmeyer holding stock options for 104,168 common shares, with exercise prices ranging from $5.36 to $8.58.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anavex Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001731122-26-000722), on May 14, 2026, and is solely responsible for the information contained therein.